ATE361092T1 - Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann - Google Patents

Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann

Info

Publication number
ATE361092T1
ATE361092T1 AT04766306T AT04766306T ATE361092T1 AT E361092 T1 ATE361092 T1 AT E361092T1 AT 04766306 T AT04766306 T AT 04766306T AT 04766306 T AT04766306 T AT 04766306T AT E361092 T1 ATE361092 T1 AT E361092T1
Authority
AT
Austria
Prior art keywords
male
follicle
sperm
stimulating hormone
chromosomal aberrations
Prior art date
Application number
AT04766306T
Other languages
English (en)
Inventor
Leo Vincenzo De
Marca Antonio La
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of ATE361092T1 publication Critical patent/ATE361092T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04766306T 2003-07-25 2004-07-23 Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann ATE361092T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03102303 2003-07-25
EP04100760 2004-02-26

Publications (1)

Publication Number Publication Date
ATE361092T1 true ATE361092T1 (de) 2007-05-15

Family

ID=34117532

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04766306T ATE361092T1 (de) 2003-07-25 2004-07-23 Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann

Country Status (13)

Country Link
US (1) US20070037742A1 (de)
EP (1) EP1673105B1 (de)
JP (1) JP4718459B2 (de)
AT (1) ATE361092T1 (de)
CY (1) CY1107697T1 (de)
DE (1) DE602004006286T2 (de)
DK (1) DK1673105T3 (de)
ES (1) ES2284052T3 (de)
HR (1) HRP20070271T3 (de)
PL (1) PL1673105T3 (de)
PT (1) PT1673105E (de)
SI (1) SI1673105T1 (de)
WO (1) WO2005011726A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1008033B (el) * 2012-03-29 2013-11-18 Βασιλειος Τσιλιβακος Μεθοδος διερευνησης της παρουσιας ενδοκυτταριων μολυσματικων παραγοντων σε κυτταρα του σπερματος
EP2968391A1 (de) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Langlebige polynukleotidmoleküle

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017557A (en) * 1987-07-24 1991-05-21 Industria Farmaceutica Serono S.P.A. Treatment of infertility with somatotrophin releasing factor
JP3045539B2 (ja) * 1989-02-21 2000-05-29 ワシントン ユニバーシティ 改変型生殖ホルモン
US5508261A (en) * 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
US5883073A (en) * 1997-04-03 1999-03-16 Washington University Single-chain double-alpha peptide

Also Published As

Publication number Publication date
US20070037742A1 (en) 2007-02-15
SI1673105T1 (sl) 2007-10-31
DK1673105T3 (da) 2007-07-02
HRP20070271T3 (en) 2007-07-31
JP2006528651A (ja) 2006-12-21
PT1673105E (pt) 2007-06-20
WO2005011726A1 (en) 2005-02-10
DE602004006286D1 (de) 2007-06-14
EP1673105B1 (de) 2007-05-02
DE602004006286T2 (de) 2008-01-03
PL1673105T3 (pl) 2007-08-31
ES2284052T3 (es) 2007-11-01
EP1673105A1 (de) 2006-06-28
CY1107697T1 (el) 2013-04-18
JP4718459B2 (ja) 2011-07-06

Similar Documents

Publication Publication Date Title
BRPI0415505A (pt) agente terapêutico para mesotelioma
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
PL356846A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
ECSP077421A (es) Compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1
ATE319465T1 (de) Therapeutische verwendung von extrakten aus sophora flavescens oder sophora subprostrata
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
TNSN08140A1 (de)
ATE451376T1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
SG163588A1 (en) Methods for identifying agents and conditions that modulate neurogenesis
TW200621804A (en) Ctla-4 antibody and aromatase inhibitor combination treatment for breast cancer
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
TW200500079A (en) Compositions and methods for treating coronavirus infection and sars
ATE443044T1 (de) Tace inhibitoren
ATE361092T1 (de) Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
TW200740816A (en) P38 MAP kinase inhibitors and methods for using the same
UY3514Q (es) Envase para perfume (blv-night woman)
TW200505906A (en) Selective mmp-13 inhibitors
PL376130A1 (en) Controlled releases system containing temozolomide
CY1106289T1 (el) Χρηση αναστολεων υποδοχεος προγεστepονης για τη θepαπευτικη αντιμετωπιση του καρκινου του μαστου που ειναι ανθεκτικος σε στepοειδη
WO2007041416A3 (en) System and method for reviewing and implementing requested updates to a primary database
MY141606A (en) N-alkoxyalkyl-substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa
ATE334681T1 (de) Verwendung von pteridinderivaten für die behandlung von erhöhtem hirndruck

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1673105

Country of ref document: EP

EEIH Change in the person of patent owner